Choline Deficiency: Fatty Liver (NAFLD)
Your liver makes fat all day long — that is part of its job — but it is supposed to wrap that fat in tiny shipping containers and send it out into the bloodstream, not stockpile it. Choline is the raw material the liver uses to build those containers. When choline runs short, the export line stalls, triglycerides pile up inside liver cells, and the organ becomes fatty — a condition doctors call hepatic steatosis, the early stage of non-alcoholic fatty liver disease (NAFLD). This page explains how a choline shortfall causes fat to accumulate in the liver, and — just as importantly — why true choline deficiency is not the reason most people have a fatty liver. For the great majority, fatty liver is driven by excess weight, insulin resistance, and alcohol; choline deficiency is a real but much narrower cause that matters most in tube-feeding (TPN), certain restrictive diets, and people who carry a specific gene variant. Encouragingly, the fatty change caused by choline deficiency is usually reversible once choline is restored.
Table of Contents
- What a Fatty Liver Feels Like
- The Mechanism: Choline Builds the Liver's Fat Trucks
- Honesty: Most Fatty Liver Is Not Choline Deficiency
- When It Points Toward Choline
- Common Situations That Cause It
- The PEMT Gene: Why Some People Need More
- Getting Tested
- Correcting Low Choline Safely
- When to Seek Care / Red Flags
- Key Research Papers
- Connections
- Featured Videos
What a Fatty Liver Feels Like
For most people, the honest answer is: it feels like nothing at all. A liver that is quietly accumulating fat usually produces no symptoms whatsoever, which is exactly why fatty liver is so often discovered by accident — on a routine blood panel showing mildly elevated liver enzymes, or on an ultrasound or scan ordered for some unrelated reason. The liver has enormous reserve capacity and few pain-sensing nerves inside it, so early steatosis is silent.
When symptoms do appear, they tend to be vague and easy to attribute to something else:
- Fatigue — a persistent, low-grade tiredness that many people simply chalk up to a busy life. It is one of the most commonly reported complaints, though it is non-specific.
- A dull ache or fullness in the upper right belly — the liver sits under the right ribs, and as it enlarges with fat its outer capsule stretches, producing a vague discomfort or a sense of fullness rather than sharp pain.
- Feeling generally “off” — some people describe malaise or trouble concentrating, but these are easily caused by dozens of other things and are not specific to the liver.
The practical takeaway: you cannot feel a fatty liver in its early stages, and you certainly cannot feel whether choline is the cause. That is why this is a problem found through testing — blood enzymes and imaging — rather than through how you feel. If a fatty liver is allowed to progress to inflammation (a stage called steatohepatitis) and then scarring, symptoms become more noticeable, but the goal is to catch and reverse it long before that.
The Mechanism: Choline Builds the Liver's Fat Trucks
To understand why a choline shortage makes the liver fatty, it helps to follow a fat molecule through the liver. The liver is constantly handling fat: it takes up fatty acids from the blood, makes new fat from extra carbohydrate, and packages triglycerides for storage or delivery elsewhere. The crucial step is export. The liver does not keep most of the fat it handles; it ships the fat out into the bloodstream inside particles called very-low-density lipoprotein (VLDL), which carry triglycerides to muscle and fat tissue to be used or stored.
Here is where choline comes in. A VLDL particle is essentially a droplet of fat wrapped in a thin outer shell, and the dominant building block of that shell is a phospholipid called phosphatidylcholine (PC). As its name says, PC is built from choline. Without enough choline, the liver cannot make enough phosphatidylcholine, and without enough PC it cannot assemble and secrete VLDL properly. The fat the liver has dutifully prepared for shipping has no container to leave in — so it stays put, accumulating as triglyceride droplets inside the liver cells. This is the heart of choline-deficiency fatty liver: a traffic jam at the export gate. The fat is being made and brought to the loading dock, but the trucks that should haul it away are not being built. This export-secretion role of phosphatidylcholine has been worked out in detail in classic studies of liver lipoprotein metabolism.
An analogy. Picture the liver as a busy warehouse that receives and produces goods (fat) all day. Normally a steady stream of delivery trucks (VLDL particles) pulls up, gets loaded, and drives the goods out to the rest of the body. Phosphatidylcholine is the material those trucks are built from, and choline is the steel that makes the phosphatidylcholine. Cut the steel supply, and the warehouse can't build enough trucks. The goods keep arriving and keep being made, but with nothing to haul them out, the loading dock and then the whole warehouse floor fill up with stacked-up inventory. The warehouse isn't broken — it's just clogged because the shipping fleet shrank. Restore the steel (choline), the trucks get built again, the backlog ships out, and the floor clears.
There is a second reason choline matters to the liver. The liver also makes phosphatidylcholine through a separate, backup route — an enzyme called PEMT (phosphatidylethanolamine N-methyltransferase) that builds PC from scratch using methyl groups rather than dietary choline. This route ties choline into the body's wider methylation economy, alongside folate, vitamin B12, and the amino acid methionine. When dietary choline is low, the body leans harder on the PEMT route, which drains methyl groups and can raise homocysteine. Conversely, when methyl donors are scarce, the body leans harder on dietary choline. The two systems prop each other up — which is why choline status, folate status, and the PEMT gene all influence how readily a given person develops a fatty liver on a low-choline diet.
Honesty: Most Fatty Liver Is Not Choline Deficiency
This is the most important section on the page, and it cuts against a lot of supplement marketing. Fatty liver is extremely common — affecting on the order of a quarter to a third of adults worldwide — and choline deficiency is the cause in only a small minority of those cases. If you have just been told you have a fatty liver, the odds overwhelmingly favor a metabolic cause, not a choline shortage.
The dominant drivers of fatty liver in the general population are:
- Excess body weight and abdominal fat — the single largest contributor. More fat tissue means more fatty acids flooding the liver.
- Insulin resistance and type 2 diabetes — when cells stop responding well to insulin, the liver both makes more fat and stores more of it. This is so central that the condition has been formally renamed MASLD (metabolic dysfunction–associated steatotic liver disease) to put metabolism front and center, replacing the older term NAFLD. See the NAFLD–MASLD connection.
- Alcohol — alcohol is processed by the liver and promotes fat accumulation directly; heavy intake causes its own alcohol-associated fatty liver disease, which can look identical on a scan.
- High intake of refined sugar, especially fructose — the liver converts excess fructose into fat very efficiently.
- Certain medications and other conditions — some drugs and rarer disorders can cause steatosis too.
So when should choline even enter the conversation? Choline deficiency becomes a plausible contributor in much narrower situations — people fed intravenously, certain very restrictive diets, and genetically susceptible individuals (covered in the next two sections). It is also worth being candid that the relationship can run the other way and overlap: studies suggest that in people who already have metabolic fatty liver, a low choline intake may make the disease somewhat worse or harder to clear, and the requirement for choline appears to rise. But “low choline can worsen existing fatty liver” is a very different claim from “choline deficiency caused your fatty liver,” and the second claim is rarely true in the general population. The right first response to a new fatty-liver diagnosis is to address weight, blood sugar, alcohol, and sugar — not to reach for a choline supplement.
When It Points Toward Choline
If most fatty liver is metabolic, what would make a clinician or an informed patient suspect that choline specifically is part of the picture? A handful of clues raise the index of suspicion — not as proof, but as reasons to look harder:
- Fatty liver in someone who is not overweight and has normal blood sugar. So-called “lean NAFLD” that doesn't fit the usual metabolic mold is more likely to have a non-metabolic contributor, and inadequate choline is one to consider.
- Long-term intravenous (parenteral) nutrition. People fed entirely by vein for weeks to months reliably develop fatty liver, and choline deficiency is a well-documented driver — standard IV nutrition historically contained little or no choline (see the next section).
- A diet very low in choline-rich foods. Choline is concentrated in eggs, liver and other organ meats, meat, fish, and to a lesser degree dairy and some plants. Diets that exclude all of these — some strict vegan patterns, very low-fat or restrictive regimens — can fall well short of the recommended intake, especially in people with higher needs.
- Post-menopausal women and people with the PEMT variant. Estrogen switches on the body's own PC-making PEMT route, so pre-menopausal women are partly protected and can make more of their own choline; after menopause, that protection fades and dietary needs rise. People carrying certain PEMT gene variants are more prone to deficiency at any age (next section).
When several of these line up — for example, a lean post-menopausal woman with an unexplained fatty liver and an egg-free, low-meat diet — choline is genuinely worth weighing as a contributing factor. Even then, it is one piece of a larger workup, not a stand-alone diagnosis. This page covers the liver consequence of low choline specifically; choline deficiency can also affect muscle (raising muscle-damage markers) and may influence memory and cognition through its role in the neurotransmitter acetylcholine — separate effects covered on their own pages.
Common Situations That Cause It
Choline-deficiency fatty liver doesn't arise from an ordinary mixed diet in a healthy person; the body is fairly resilient. It shows up in specific circumstances where intake is genuinely inadequate or needs are unusually high:
- Total parenteral nutrition (TPN). This is the clearest, best-documented cause. People who receive all their nutrition intravenously — because their gut cannot be used — develop fatty liver at high rates, and controlled trials showed that adding choline to the IV formula reversed the hepatic abnormalities. For decades, standard parenteral formulas were not supplemented with choline, making deficiency essentially built-in for long-term TPN patients.
- Very restrictive or choline-poor diets. Because the richest sources are eggs and organ meats, dietary patterns that eliminate animal foods — or that are simply low in variety — can fall short of the Adequate Intake, particularly when combined with higher needs (pregnancy, menopause, the PEMT variant). National surveys consistently find that a large share of people, and most pregnant women, do not reach the recommended intake.
- Pregnancy and breastfeeding. The developing fetus and the breast draw heavily on the mother's choline, sharply increasing requirements. While the headline concern in pregnancy is fetal brain development (covered under Choline & the Liver and the Benefits pages), the rising demand also makes maternal stores easier to deplete.
- Low intake of supporting methyl donors. Because the body can partly make its own phosphatidylcholine using methyl groups, a diet also low in folate, vitamin B12, and methionine removes that backup and makes dietary choline more critical. Conversely, generous folate can spare some choline.
- Genetic susceptibility (the PEMT variant). Common variations in the PEMT gene blunt the body's ability to make its own PC, so carriers run short on a low-choline diet far sooner than others — described in detail next.
It is the combination of these that matters most. A young man eating eggs and meat will rarely become choline deficient; a post-menopausal woman with a PEMT variant on a low-choline, low-folate diet is a very different story.
The PEMT Gene: Why Some People Need More
One of the most important and most under-appreciated facts about choline is that the amount a person needs is not the same for everyone — it is shaped by sex, hormonal status, and genetics. The central player is the gene that codes for the PEMT enzyme, the liver's tool for making phosphatidylcholine from scratch without dietary choline.
Two things govern how much PC your body can make this way:
- Estrogen turns PEMT on. The PEMT gene is responsive to estrogen, so pre-menopausal women can ramp up their own PC production and are partly insulated from low dietary choline. This is a major reason men and post-menopausal women are more likely than younger women to develop signs of deficiency &mdash including fatty liver and muscle damage — when choline is restricted. Carefully controlled feeding studies found that men and post-menopausal women developed organ dysfunction on a low-choline diet far more readily than pre-menopausal women.
- Common gene variants weaken PEMT. A sizeable fraction of people carry single-letter variations (single-nucleotide polymorphisms) in or near the PEMT gene that reduce the enzyme's activity, blunting estrogen's ability to switch it on. For these individuals, the body's backup PC factory runs poorly, so they depend much more heavily on dietary choline and can develop fatty liver and other signs of deficiency on intakes that leave others perfectly healthy.
The practical meaning is humbling: there is no single “safe” choline intake that protects everyone, and you cannot tell from the outside who carries a susceptible variant. This genetic variation is precisely why population studies of choline and fatty liver can look murky — the people who benefit most from extra choline are a genetically defined subgroup, not the average eater. It also reinforces the page's main message: choline matters, but as a modifiable risk factor in susceptible people, not as the universal cause of fatty liver.
Getting Tested
There are two separate questions here: do you have a fatty liver? and is choline part of the cause? The first is straightforward to answer; the second is genuinely difficult, because there is no simple, reliable blood test for whole-body choline status.
Detecting the fatty liver itself:
- Liver function tests (ALT and AST) — a routine blood draw. Fatty liver often (but not always) produces a mild rise in these liver enzymes, with ALT typically higher than AST in metabolic fatty liver. Normal enzymes do not rule out steatosis, however.
- GGT — another liver enzyme that can be elevated and is sensitive to alcohol and fatty change.
- Imaging — ultrasound is the usual first step and shows a “bright” fatty liver; specialized MRI techniques can actually quantify the fat percentage. Imaging, not blood work, is what confirms steatosis.
Sorting out the cause — including the role of choline — is mostly done by context, not by a choline assay:
- A fasting insulin level and an A1C / metabolic panel reveal insulin resistance and diabetes — the metabolic causes that must be addressed first.
- An honest alcohol history is essential, because alcohol-associated and metabolic fatty liver overlap.
- A careful dietary history — especially intake of eggs, meat, organ meats, and fish — is how a clinician estimates whether choline is likely to be low. Plasma choline can be measured but is tightly regulated and a poor reflector of tissue stores, so it is not a routine diagnostic test. A high homocysteine can be a downstream clue that the methylation system (which choline feeds into) is strained.
In short: imaging and liver enzymes find the fatty liver; the choline contribution is inferred from who you are and what you eat, because a clean “choline level” test does not exist. This is another reason the metabolic causes — which can be measured — are pursued first.
Correcting Low Choline Safely
Because choline-deficiency fatty liver is usually reversible, the encouraging news is that restoring adequate choline — in the people for whom choline is genuinely the problem — can clear the excess liver fat. The approach is food first, then supplements only where warranted, and always alongside fixing the metabolic drivers.
- Food first. The richest sources of choline are eggs (the yolk is exceptionally high), liver and organ meats, and other meats and fish; legumes, cruciferous vegetables, and some nuts contribute smaller amounts. For most people, a couple of eggs and regular protein cover the day's needs comfortably. See the choline food sources page for the numbers.
- Know the target intake. Choline does not have a classic RDA; instead authorities set an Adequate Intake (AI) — about 550 mg/day for adult men and 425 mg/day for women, rising in pregnancy (~450 mg) and lactation (~550 mg). European authorities (EFSA) set a similar reference of roughly 400 mg/day for adults. Most people in surveys fall short of these figures, though falling short of an AI is not the same as clinical deficiency.
- Supplements, when food isn't enough. For people with documented inadequate intake, higher needs, or a susceptible profile, choline supplements (choline bitartrate, or phosphatidylcholine) and lecithin can fill the gap. Doses are individualized; more is not better.
- Mind the methyl partners. Adequate folate, vitamin B12, and protein (for methionine) support the body's own PC-making route and lighten the load on dietary choline.
- Address the real cause in parallel. Since most fatty liver is metabolic, the cornerstones remain weight reduction if overweight, improving insulin sensitivity through diet and activity, cutting alcohol and added sugar, and treating diabetes. Restoring choline helps the choline-deficient subgroup; it does not substitute for metabolic treatment in everyone else.
A word of caution: very high choline intake is not benign. Extremely large doses can cause a fishy body odor, sweating, low blood pressure, and gut upset, and the gut conversion of excess choline to a compound called TMAO has been studied in relation to cardiovascular risk. Aim for adequacy from food, supplement deliberately when there's a reason, and avoid mega-dosing.
When to Seek Care / Red Flags
Most fatty liver — whatever the cause — is silent and is managed unhurriedly through diet, weight, and metabolic care with a clinician. But certain features mean you should get medical attention promptly, because they suggest the liver problem has advanced beyond simple fat or that something more serious is going on:
- Yellowing of the skin or the whites of the eyes (jaundice) — a sign the liver may not be clearing bilirubin and warrants prompt evaluation.
- Swelling of the abdomen or the legs and ankles — fluid build-up can signal advanced liver disease (cirrhosis) and needs medical assessment.
- Vomiting blood, or black, tarry stools — a medical emergency that can reflect bleeding related to advanced liver disease; call for help immediately.
- Confusion, marked drowsiness, or personality change — can indicate the liver is failing to clear toxins; seek urgent care.
- Persistent or worsening pain in the upper-right abdomen, especially with fever or feeling unwell.
- Unexplained easy bruising or bleeding, which can reflect impaired liver function.
Short of these emergencies, the appropriate path for a newly found fatty liver is a non-urgent but real conversation with a clinician: confirm it on imaging, check liver enzymes and metabolic labs, review alcohol and diet, and make a plan. Catching and reversing fatty liver early — whether the lever is weight, sugar, alcohol, or, in the right person, choline — is what keeps it from progressing to inflammation and scarring.
Key Research Papers
- Corbin KD, Zeisel SH (2012). Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Current Opinion in Gastroenterology;28(2):159-165. — DOI: 10.1097/MOG.0b013e32834e7b4b
- Spencer MD, Hamp TJ, Reid RW, et al. (2011). Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency. Gastroenterology;140(3):976-986. — DOI: 10.1053/j.gastro.2010.11.049
- Buchman AL, Ament ME, Sohel M, et al. (2001). Choline Deficiency Causes Reversible Hepatic Abnormalities in Patients Receiving Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition;25(5):260-268. — DOI: 10.1177/0148607101025005260
- Cole LK, Vance JE, Vance DE (2012). Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochimica et Biophysica Acta (Molecular and Cell Biology of Lipids);1821(5):754-761. — DOI: 10.1016/j.bbalip.2011.09.009
- Li Z, Vance DE (2008). Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasis. Journal of Lipid Research;49(6):1187-1194. — DOI: 10.1194/jlr.R700019-JLR200
- Fischer LM, da Costa KA, Kwock L, et al. (2007). Sex and menopausal status influence human dietary requirements for the nutrient choline. The American Journal of Clinical Nutrition;85(5):1275-1285. — DOI: 10.1093/ajcn/85.5.1275
- Zeisel SH, da Costa KA (2009). Choline: an essential nutrient for public health. Nutrition Reviews. — PubMed
- Sanders LM, Zeisel SH (2007). Choline: Dietary Requirements and Role in Brain Development. Nutrition Today;42(4):181-186. — DOI: 10.1097/01.NT.0000286155.55343.fa
- da Costa KA, Niculescu MD, Craciunescu CN, et al. (2006). Choline deficiency increases lymphocyte apoptosis and DNA damage in humans. The American Journal of Clinical Nutrition;84(1):88-94. — DOI: 10.1093/ajcn/84.1.88
- EFSA Panel on Dietetic Products, Nutrition and Allergies (2016). Dietary Reference Values for choline. EFSA Journal;14(8):4484. — DOI: 10.2903/j.efsa.2016.4484
- Chalasani N, Younossi Z, Lavine JE, et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology;67(1):328-357. — DOI: 10.1002/hep.29367
- Rinella ME, Lazarus JV, Ratziu V, et al. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology;78(6):1966-1986. — DOI: 10.1097/HEP.0000000000000520
PubMed Topic Searches
- PubMed — Choline deficiency and hepatic steatosis
- PubMed — Phosphatidylcholine and VLDL secretion from the liver
- PubMed — PEMT polymorphism, choline, and NAFLD
- PubMed — Parenteral nutrition and choline-related steatosis
- PubMed — Choline intake and NASH severity
Connections
- Choline Deficiency Hub
- Choline Deficiency and Muscle Damage
- Choline Deficiency and Memory & Cognition
- Choline Toxicity Hub
- Choline Overview
- Phosphatidylcholine
- Lecithin
- Choline and the Liver (NAFLD)
- Choline Food Sources
- History of Choline
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- The NAFLD–MASLD Connection
- Insulin Resistance
- Liver Function Tests (ALT/AST)
- GGT
- Fasting Insulin
- Homocysteine
- Folate, Methylation & Homocysteine
- Methionine, Methylation & SAMe
- Eggs
- Beef Liver